Skopos Labs, Inc. Cabot Corp Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Cabot Corp stock. As of the latest transaction made, Skopos Labs, Inc. holds 678 shares of CBT stock, worth $51,039. This represents 0.01% of its overall portfolio holdings.
Number of Shares
678
Previous 41
1553.66%
Holding current value
$51,039
Previous $3,000
1766.67%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CBT
# of Institutions
435Shares Held
50.2MCall Options Held
50.7KPut Options Held
43.4K-
Black Rock Inc. New York, NY7.22MShares$544 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.1MShares$459 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.24MShares$319 Million0.07% of portfolio
-
Earnest Partners LLC Atlanta, GA3.23MShares$243 Million1.33% of portfolio
-
State Street Corp Boston, MA2.03MShares$153 Million0.01% of portfolio
About CABOT CORP
- Ticker CBT
- Exchange NYSE
- Sector Basic Materials
- Industry Specialty Chemicals
- Shares Outstandng 56,299,200
- Market Cap $4.24B
- Description
- Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such...